Brief: XSpray Pharma Gets Additional Product Patent In The US
04/12/2018 07:10
Dec 4 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* ADDITIONAL PRODUCT PATENT IN THE UNITED STATES FOR
HYNAP-DASA
* NEW PATENT WILL EXPIRE JANUARY 11, 2033
Source text for Eikon: ID:nWkr7f2lW0
Further company coverage: XSPRAY.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003